(Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
December 12, 2022 08:05 ET
|
Aridis Pharmaceuticals, Inc.
Los Gatos, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company today announced the Cystic Fibrosis Foundation invested $4.85 million in...
Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
December 12, 2022 07:00 ET
|
Aridis Pharmaceuticals, Inc.
Los Gatos, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company today announced the Cystic Fibrosis Foundation invested $4.85 million in...